1 / 10

Aarkstore - Primary Biliary Cirrhosis - Pipeline Review, H2

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Browse full report @ http://goo.gl/422xKG

kaveriRai9023
Download Presentation

Aarkstore - Primary Biliary Cirrhosis - Pipeline Review, H2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmaceutical and Healthcare Market Research Report Primary Biliary Cirrhosis - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

  2. Summary Primary Biliary Cirrhosis - Pipeline Review, H2 2014, provides an overview of the Primary BiliaryCirrhosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Primary Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Primary Biliary Cirrhosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. For More Information Visit : www.aarkstore.com

  3. Scope • The report provides a snapshot of the global therapeutic landscape of Primary Biliary Cirrhosis- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Primary Biliary Cirrhosis and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Primary Biliary Cirrhosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Primary Biliary Cirrhosis pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products For More Information Visit : www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Primary Biliary Cirrhosis- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Primary Biliary Cirrhosis pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

  5. Table of Content Global Markets Direct Report Coverage 6Primary Biliary Cirrhosis Overview 7Therapeutics Development 8Pipeline Products for Primary Biliary Cirrhosis - Overview 8Pipeline Products for Primary Biliary Cirrhosis - Comparative Analysis 9Primary Biliary Cirrhosis - Therapeutics under Development by Companies 10Primary Biliary Cirrhosis - Pipeline Products Glance 12Late Stage Products 12Clinical Stage Products 13Early Stage Products 14Primary Biliary Cirrhosis - Products under Development by Companies 15Primary Biliary Cirrhosis - Companies Involved in Therapeutics Development 16AlbireoPharma 16Dr. Falk Pharma GmbH 17GlaxoSmithKline plc 18Intercept Pharmaceuticals, Inc. 19Johnson & Johnson 20 For More Information Visit : www.aarkstore.com

  6. List of Tables Number of Products under Development for Primary Biliary Cirrhosis, H2 2014 8Number of Products under Development for Primary Biliary Cirrhosis - Comparative Analysis, H2 2014 9Number of Products under Development by Companies, H2 2014 11Comparative Analysis by Late Stage Development, H2 2014 12Comparative Analysis by Clinical Stage Development, H2 2014 13Comparative Analysis by Early Stage Development, H2 2014 14Products under Development by Companies, H2 2014 15Primary Biliary Cirrhosis - Pipeline by AlbireoPharma, H2 2014 16Primary Biliary Cirrhosis - Pipeline by Dr. Falk Pharma GmbH, H2 2014 17Primary Biliary Cirrhosis - Pipeline by GlaxoSmithKline plc, H2 2014 18Primary Biliary Cirrhosis - Pipeline by Intercept Pharmaceuticals, Inc., H2 2014 19Primary Biliary Cirrhosis - Pipeline by Johnson & Johnson, H2 2014 20Primary Biliary Cirrhosis - Pipeline by MediGene AG, H2 2014 21Primary Biliary Cirrhosis - Pipeline by NGM Biopharmaceuticals, Inc., H2 2014 22Primary Biliary Cirrhosis - Pipeline by Shire Plc, H2 2014 23Primary Biliary Cirrhosis - Pipeline by Virobay Inc., H2 2014 24 For More Information Visit : www.aarkstore.com

  7. List of Figures Number of Products under Development for Primary Biliary Cirrhosis, H2 2014 8Number of Products under Development for Primary Biliary Cirrhosis - Comparative Analysis, H2 2014 9Number of Products under Development by Companies, H2 2014 10Comparative Analysis by Clinical Stage Development, H2 2014 13Assessment by Monotherapy Products, H2 2014 25Number of Products by Top 10 Targets, H2 2014 26Number of Products by Stage and Top 10 Targets, H2 2014 27Number of Products by Top 10 Mechanism of Actions, H2 2014 28Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 29Number of Products by Top 10 Routes of Administration, H2 2014 30Number of Products by Stage and Top 10 Routes of Administration, H2 2014 31Number of Products by Top 10 Molecule Types, H2 2014 32Number of Products by Stage and Top 10 Molecule Types, H2 2014 33 For More Information Visit : www.aarkstore.com

  8. Related Reports Fabry Disease-Pipeline Insights, 2015 Ocular Hypertension-Pipeline Insights, 2015 Fallopian Tube Cancer-Pipeline Insights, 2015 Ocular Inflammation-Pipeline Insights, 2015 Familial AdenomatousPolyposis Coli-Pipeline Insights, 2015 Ocular Pain-Pipeline Insights, 2015 Oligodendroglioma-Pipeline Insights, 2015 Familial Chylomicronemia (Type I Hyperlipoproteinemia)-Pipeline Insights, 2015 For More Information Visit : www.aarkstore.com

  9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related